Regulatory and early-loss risks in the referral and telemedicine business for patients living overseas
First written in FY2024. 1 of 2 entries say "Restated". Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026RestatedAnnual report
「During the fiscal year ended March 2024, our group launched a business referring patients living overseas to domestic medical institutions and a business referring such patients to telemedicine services.」
The risks of regulation, personal data protection and prolonged losses caused by front-loaded investment in the referral and telemedicine business for patients living overseas continue. - FY2024First statedAnnual report
「During the consolidated accounting year under review, our group launched, for the first time, a business referring patients living overseas to domestic medical institutions and a business referring such patients to telemedicine services. These businesses are also new businesses for our group, and because investment will precede returns for the time being, losses will continue until stable operations can be established.」
For referrals and telemedicine services for patients living overseas, regulations governing the provision of economic benefits to medical institutions, personal data protection regulations in Japan and overseas, and prolonged losses caused by front-loaded investment were identified as risks for the first time.